The European artificial tear market is growing at a significant CAGR of 4.6% during the forecast period. The market is growing due to various factors such as the increasing prevalence of dry eye syndrome. Artificial tears are used to lubricate dry eyes and moisturize the outer surface of the eyes. It is also used to treat dry eyes caused due to surgery, certain medical conditions, medications aging, and smoky or windy conditions, among others. The incidence and prevalence of dry eye are rising among the population, especially in developed nations of Europe. Dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. For instance, in April 2020, according to a study ‘National Health and Wellness Survey’ conducted in Germany, ~7.4 million people were diagnosed with dry eye. The data also stated that the prevalence has gone up by 2.7% among people of age 18?34 years. Additionally, the prevalence was 18.6% among older people. Based on sex, the percentage of prevalence was higher in women; it accounted for 8.8% than men with 4.5%.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/european-artificial-tears-market
However, various factors are restraining the market growth including side effects caused by artificial tears resulting in eye pain, red eyes, irritation, among others. Although, innovations such as preservative-free artificial tears in artificial tears could be perceived as a major opportunity for the players engaged in the market.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/european-artificial-tears-market
The European artificial tears market is segmented based on type, application, and delivery method. Based on type, the market is segmented into cellulose-derived tears, glycerin-derived tears, oil-based emulsion tears, polyethylene glycol- & propylene glycol-based tears. Based on application, the market is fragmented into dry type treatment, contact lens moisture, others. Based on the delivery method, the market is bifurcated into eye drops and, ointments.
Geographically, the market is classified into the UK, Germany, France, Spain, Italy, and the Rest of Europe. While, the key companies included in the report of the European artificial tear market are Abbott Medical Optics Inc., Akorn, Inc., Alcon Laboratories, Inc., Allergan, Inc., Bausch and Lomb, Johnson & Johnson, Novartis International AG, Ocusoft Inc., Rohto Pharmaceutical Co., Ltd, Santen Pharmaceutical Co. Ltd, Similasan Corp., URSAPHARM Arzeinmittel GmbH, WUHAN Yuanda, among more. The companies operating in the artificial tears market are constantly focusing on product launches covering a wide range of users, R&Ds, partnerships, M&As, and technological advancements. The report also includes a detailed market overview, strategic recommendations, key company analysis, key findings, analyst insights, predictive analysis, pipeline analysis, market determinants, market segmentation, geographical analysis, and company profiling of the market.
Market Segmentation
European Artificial Tears Market by Type
- Cellulose-Derived Tears
- Glycerin-Derived Tears
- Oil-Based Emulsion Tears
- Polyethylene Glycol- & Propylene Glycol-Based Tears
European Artificial Tears Market by Application
- Dry Type Treatment
- Contact Lens Moisture
European Artificial Tears Market Delivery Method
- Eyedrops
- Ointments
Regional Analysis
Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Company Profiles
- Abbott Medical Optics, Inc.
- Akorn, Inc.
- Alcon, Inc.
- Allergan, PLC
- Bausch And Lomb, Inc.
- Carl Zeiss Meditec AG
- Johnson And Johnson Service, Inc.
- Nicox S.A.
- Novagali Pharma S.A.
- Novamedica LLC
- Novartis International AG
- Novaliq GMBH
- Ocusoft Inc.
- Shire PLC
- Similasan Corp.
- Sylentis S.A.
- Ursapharm Arzneimittel GmbH
- Ziemer Ophthalmic System AG
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
